Jump to content
IndiaDivine.org

Treating Diabetes With Enzymes: What We Know Now.

Rate this topic


Guest guest

Recommended Posts

Guest guest

My Comments: Personally, I have found that Systemic Enyzmes with no fillers

are far more effective then those that do have fillers and cheaper too as one

can take less per day for the same effects.

Treating Diabetes With Enzymes: What We Know Now.

By: Dr. William Wong, ND, PhD.

_http://www.totalityofbeing.com/FramelessPages/Articles/TreatingDiabetes.htm_

(http://www.totalityofbeing.com/FramelessPages/Articles/TreatingDiabetes.htm)

 

 

Up to a year ago, for anyone asking if systemic enzymes could help lessen

the load of troubles that beset Type 1 diabetic patients, I would have told

them about lowering pancreatic inflammation, and possibly helping with lower

extremity circulatory issues. I would have never suggested that the use of

enzymes could decrease the need for insulin, increase energy or reverse the

seemingly myriad of things diabetics suffer from. Then we started getting

information from Type 1 patients that amazed even me and that have subsequently

sparked new research. Here are two typical case histories.

Case History #1:

A Type 1 diabetic Native American patient from Montana in his mid 40's, very

insulin dependent, with peripheral neuropathy in the lower extremities

(LE's) and presenting paresthesia as well in the upper extremities (UE's)

radiating distally to the hand. Peripheral Vascular Disease (PVD) in the LE's

had

already caused several toes to be amputated.

Patient began taking therapeutic doses of fibrinolytic systemic enzymes.

Within weeks, circulation was opened in his feet and lower extremities. Skin

there returned to a pink / flesh color. Remaining toes now have full

circulation and are no longer candidates for amputation. Lower extremity and

upper extremity pain became paresthesia (tingling and pins and needles), and as

a result is much more bearable.

The patient’s insulin needs were decreased.

Case History #2:

86-year-old male Caucasian from Las Vegas history of Type 1 Diabetes for

over 50 years. One below the knee amputation (left side) already done due to

DVP, the other leg about to be amputated due to general lack of blood flow and

arterial blockage. Poor circulation body wide and a gray / white pallor to

the skin also body wide. Neurological pain was had at both lower extremities.

Urine flow beginning to flag as patients kidneys became laden with scar

tissue (Glomerulosclerosis). Patient was highly insulin dependent. Above

that the patient was functionally blind in one eye from a Lasix procedure that

had generated scar tissue over the retina.

After several weeks of systemic enzyme use the patient first noticed a

lessening in his lower extremity neurological pain (neuropathy). His skin

color

in the remaining leg changed to rosy as circulatory pathways were opening.

Outer layer of whitish dead skin shed off leaving what resembled a “body wide

dandruffâ€, exposing new pink /flesh tone skin beneath. The existing leg

became pink with blood flow, no longer ulcered, no longer had ischemic pain and

was saved from amputation.

Urine flow increased as fibrin was lysed (eaten away) from the kidneys. If

the urine was allowed to stand in the toilet a layer of tiny bits of fibrin

(component of scar tissue) in what resembled fiberglass floated to the top.

The fibrosis that had blinded one eye was lysed away and the patient now has

better than 20/20 vision in that eye. Most significantly, the patients own

insulin production has returned (thought to be impossible under the auto immune

theory of diabetic pancreatic destruction). He is no longer insulin

dependent. After medical testing the patient is no longer considered diabetic

at

all and is off all medication.

Sound fantastic? It did to me, even as a Naturopath who expects nature to

do fantastic things. Diabetes is one of those diseases you never expect

patients to get better from. Even after several years of working with

systemic

enzymes I had heard of some Type 2 patients improving their energy and

leveling off their sugar highs and lows but I had never expected any form of

improvement in Type 1 patients, the medical literature was very clear. Once

the

immune system destroyed the insulin producing portions of the pancreas, there

was no getting those tissues to function again! That medical “truth†has

turned out to be merely a medical theory.

Lets take a look at the present understanding of the root causes of diabetes

and add our own conjectures based on what we have observed clinically. We

know from the present research work being done that the root cause of

diabetes is inflammation of the pancreas. How and why this inflammation sets

in we

yet do not know. As we also know from the physiology of trauma, inflammation

breeds fibrosis or scar tissue. One follows a chronic course of the other.

 

Fibrosis is also the culprit in the Peripheral Vascular Disease. In this

condition, fibrin plugs form in the micro circulation (tiny blood vessels)

forming blockages to full blood flow. Fibrin also forms the matrix for

arterial

plaque. Inflammation of trauma to the inner lining of an artery (intima),

causes the traumatized or weakened section to shore itself up with scar tissue.

On the spider web of scar tissue fat, calcium and heavy metals accrue

forming what we know as arterial plaque. Once the fibrosis blockages become

extensive enough, the patient presents the signs of PVD, which are cold

extremities, intermittent caludication (pain on walking from lack of oxygen

supply to

the tissues known as ischemia), non healing ulcerations of the skin and

eventual death of tissue creating gangrene leading to amputation.

The high blood sugar levels had during diabetes damages the body’s organs.

One of the first organs to be damaged are the nerves to the legs and then the

arms. Wherever the circulation is poorest the nerve damage follows and

radiating nerve pain is had (neuropathy). The damage begins with, you

guessed it, inflammation and progresses with, you guessed it again, fibrosis.

It is this inflammation into fibrosis that seems to be a recurring theme in

diabetes.

For a moment lets do some education on orally administered systemic enzymes.

They have a 5 decade history of wide spread medical use in Germany, Central

Europe and Japan with over 150 million patients in Europe alone having

undergone enzyme therapy in the last 4 decades. There are over 200

peer-reviewed studies proving the absorption, therapeutic action and total lack

of

toxicity (no LD-50) of systemic enzymes. Their primary action is

anti-inflammatory, (though not through a COX 1 or Cox 2 action. The enzymes

instead “eatâ€

pro inflammatory cytokines). The enzymes also have a proven lysing action on

all types of fibrosis and scar tissue leaving normal or endogenous tissue

entirely intact and un-bothered. This is due to the body “taggingâ€

excesses of

fibrin as exogenous proteins. (The subject of protein tagging and its

discoverer won the Nobel Prize in biology in the late '90's). Entering the key

words: systemic enzyme, serrapeptase, nattokinase, bromelain, pancreatin,

papain, trypsin, chymo trypsin into the search engine at Pub Med will bring up

some

of the current research on systemic enzymes and their applications. A

search in the “medical fields†section of _www.mucos.cz_

(http://www.mucos.cz/)

will show abstracts of the extensive older research done with the first

systemic enzyme blends of the 50's and 60's. It has to be said that there is

nothing, no drug or substance, in either the allopathic medical world or in the

natural health world that can remove scar tissue but highly fibrinolytic

systemic enzymes.

Current thinking on diabetes is that the body’s immune system attacks the

pancreas creating inflammation. This may be so. Further, the current thinking

is that the inflammation brings about the destruction of the Islets of

Langerhans and its Beta Cells, the places where insulin is made. This may not

be

so. If the studies that are currently being planned and executed further

demonstrate what we are seeing clinically with Type 1 patients on systemic

enzymes, then this point will have to be re-thought. Clinically most of the

Type

1 patients have a significantly lower need for insulin while some no longer

need the insulin at all. This would suggest that the Beta Cells and the

Islets are not destroyed. I conjecture that they are merely clogged by the

fibrosis created by the inflammation. Once the causative inflammation is

reduced

and once the fibrinolytic action of the enzymes has eaten away the fibrosis

and reopened the channels, then what ever production the Islets can make can

actually get into the system.

I believe that the global (body wide) non-toxic, anti-inflammatory effects

of highly fibrinolytic systemic enzymes and the scar tissue eating effects of

the same enzymes are the reasons we are seeing the decrease in pancreatic

inflammation, decrease in diabetic neuropathy, in it's associated Peripheral

Vascular Disease, and the decrease in insulin dependence we are seeing

clinically in Type 1 patients. Let's see if the research further verifies the

observed findings and gives us more insight into the pathways of action.

 

 

 

 

 

 

 

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...